The tech giant is set to report earnings as AI spending faces scrutiny. Here's what to expect.

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...

Faricimab demonstrated noninferior vision gains and improved anatomical outcomes among patients with diabetic macular edema ...

Among patients with prostate cancer, a high omega-3, low-omega-6 diet with fish oil led to a Ki-67 index decrease.

Boehringer Ingelheim’s lung disease drug nerandomilast has been successful in a Phase III study paving the way for the ...

Qureight Ltd, the Core Imaging Laboratory developing deep-learning image analytics, and Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on developing inhaled therapies to treat ...

A research team at UCLA has developed a deep learning-powered chemiluminescence vertical flow assay (CL-VFA) that brings ...

NSYNC’s Lance Bass shares his journey with type 1.5 diabetes, also known as latent autoimmune diabetes in adults (LADA). The ...

AI offers solutions to many of the challenges faced by India's healthcare system, especially in terms of dealing with a ...

A Manchester-based medtech company has secured funding from the GMC Life Sciences Fund By Praetura, and through NPIF II – Praetura Equity Finance, to continue scaling its ...

We sat down with Pro Medicus CEO, Dr Sam Hupert on results day to discuss the past six months and the all-important outlook.